BRCA2 and cancer: Finally, we show that CAM833 inhibits the cellular response to DNA damage, potentiating in BRCA2 wild-type cells the cytotoxic effects both of ionizing radiation or of PARP1 inhibitors, opening future avenues for anti-cancer drug development.